CNBC · General

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline

· By Elsa Ohlen, Angelica Peebles
Story summary

Pharma giant Merck is buying U.S. biotech firm Terns Pharmaceuticals for $6.7 billion, the company said Wednesday.

Read at CNBC

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.